retatrutide fda status CT Health News | Doctors are warning patients against using unapproved versions of retatrutide, an experimental Eli Lilly weight loss drug still in clinical ⚠️ BEWARE OF RETATRUTIDE SOLD

During the weight loss phase changes in food selection, reduction in appetite, and changes in gastrointestinal hormone levels are known to play a significant role [3]

This is because it still needs to undergo thorough testing to ensure its safety and effectiveness

always follow the device-specific instructions provided by your clinical trial team, and ensure you have received hands-on training before self-injecting

Wegovy is approved to help manage weight loss

Disclaimer: Always consult with your healthcare provider before choosing a compounding pharmacy for weight loss drugs as they can guide you in choosing a reputable one that suits your needs, before deciding which pharmacy to purchase from

Management of obesity in Cardiovascular Practice: JACC Focus Seminar